Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127165702 | 12716570 | 2 | F | 201609 | 20160902 | 20160906 | 20160909 | PER | US-PFIZER INC-2016417188 | PFIZER | 65.00 | YR | M | Y | 0.00000 | 20160909 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127165702 | 12716570 | 1 | PS | EFFEXOR XR | VENLAFAXINE HYDROCHLORIDE | 1 | 75 MG, 1X/DAY (75MG ER HCL, ONCE A DAY IN THE MORNING) | U | 20699 | 75 | MG | PROLONGED-RELEASE CAPSULE | QD | ||||||
| 127165702 | 12716570 | 2 | SS | EFFEXOR | VENLAFAXINE HYDROCHLORIDE | 1 | UNK | 20699 | TABLET |
Indications of drugs used
| no results found |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127165702 | 12716570 | Drug ineffective | |
| 127165702 | 12716570 | Hyperhidrosis | |
| 127165702 | 12716570 | Malaise | |
| 127165702 | 12716570 | Nausea | |
| 127165702 | 12716570 | Sensory disturbance | |
| 127165702 | 12716570 | Withdrawal syndrome |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127165702 | 12716570 | 1 | 20160901 | 0 |